China SXT Pharmaceuticals Inc. (SXTC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    China SXT Pharmaceuticals...

    NASDAQ: SXTC · Real-Time Price · USD
    1.66
    0.01 (0.61%)
    At close: Oct 03, 2025, 3:44 PM
    1.60
    -3.61%
    After-hours: Oct 03, 2025, 04:48 PM EDT

    China SXT Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 1.74M 1.93M 1.97M 2.6M 4.78M
    Cost of Revenue
    		 1.37M 1.37M 1.55M 1.35M 1.94M
    Gross Profit
    		 367.43K 553.97K 426.27K 1.25M 2.84M
    Operating Income
    		 -2.68M -2.52M -5.61M -5.19M -2.2M
    Interest Income
    		 n/a n/a n/a n/a n/a
    Pretax Income
    		 -3.3M -3.1M -5.93M -5.41M -2.94M
    Net Income
    		 -3.3M -3.1M -5.93M -5.74M -2.75M
    Selling & General & Admin
    		 3.05M 3.07M 6.03M 6.44M 5.04M
    Research & Development
    		 191.39K 184.19K n/a n/a n/a
    Other Expenses
    		 -191.39K -184.19K n/a n/a n/a
    Operating Expenses
    		 3.05M 3.07M 6.03M 6.44M 5.04M
    Interest Expense
    		 648.22K 544.28K 476.78K 36.7K 1.62M
    Selling & Marketing Expenses
    		 289.86K 433.57K 387.45K 924.54K 1.59M
    Cost & Expenses
    		 4.42M 4.44M 7.58M 7.79M 6.97M
    Income Tax Expense
    		 n/a n/a n/a 328.15K -192.68K
    Shares Outstanding (Basic)
    		 403.92K 867.42K 266.97K 41.59K 28.78K
    Shares Outstanding (Diluted)
    		 403.92K 867.42K 266.97K 41.59K 28.78K
    EPS (Basic)
    		 -8.18 -3.57 -22.23 -137.92 -95.48
    EPS (Diluted)
    		 -8.18 -3.57 -22.23 -137.92 -95.48
    EBITDA
    		 -2.57M -2.35M -5.21M -5.05M -1.85M
    EBIT
    		 -2.66M -2.55M -5.46M -5.37M -2.2M
    Depreciation & Amortization
    		 82.3K 203.25K 250.16K 320.01K 345.41K

    Add to Watchlist